Chloride Channel Activator
20 drugs across 11 manufacturers|17 Generic,3 Brand
The Chloride Channel Activator class contains 20 NDCs from 11 manufacturers (17 generic, 3 brand), at an average NADAC of $1.46 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
20
17G / 3B
Manufacturers
11
Avg $1.4622/unit
Avg 7d Change
+3.60%
Across 17 drugs with changes
7d Activity
of 20 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
11 manufacturers producing drugs in this therapeutic class(2 pricing outliers)
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
SpecGx LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
lubiprostone market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Chloride Channel Activator class?
The Chloride Channel Activator class contains 20 NDCs from 11 manufacturers — 17 generic and 3 brand products.
What is the average price of Chloride Channel Activator drugs?
The average NADAC for the Chloride Channel Activator class is $1.4622 per unit across 20 NDCs.
Is generic cheaper than brand in the Chloride Channel Activator class?
Among products priced per EA, the average generic NADAC in this class is $0.6105, versus $6.2888 for brand — brand products average about 10× the generic price.
Which manufacturers make Chloride Channel Activator drugs?
11 manufacturers make drugs in the Chloride Channel Activator class. Ranked by number of NDCs, the largest are SpecGx LLC (2), Par Health USA, LLC (2), Teva Pharmaceuticals USA Inc. (2), Camber Pharmaceuticals Inc. (2), Dr. Reddy's Laboratories Inc. (2).
How has Chloride Channel Activator pricing changed recently?
Over the past 7 days, 17 NDCs in this class rose and 0 fell, with a class-wide average change of +3.6%.